or Try an Advanced Search...

    Oncology Focused Biopharmaceutical Stocks List

    Symbol Grade Name % Change
    CTMX D CytomX Therapeutics, Inc. -5.20
    CMPX F Compass Therapeutics, Inc. -0.67
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Angiogenesis Antibodies Clinical Medicine Compugen Human Diseases Immune Checkpoint Immune System Immunogen Life Sciences Medicine Monoclonal Antibody Therapy Oncology Tumor Tumor Microenvironment

    Related ETFs - A few ETFs which own one or more of the above listed Oncology Focused Biopharmaceutical stocks.

    Symbol Grade Name Weight
    FORH A Formidable ETF 2.33
    IWC C iShares Microcap ETF 0.08
    IWN C iShares Russell 2000 Value ETF 0.01
    IWM C iShares Russell 2000 ETF 0.01
    IWV B iShares Russell 3000 ETF 0.0
    View all Oncology Focused Biopharmaceutical ETFs...
    Compare ETFs
    Compare FORH to IWV Compare IWC to IWV Compare IWN to IWV

        Oncology Focused Biopharmaceutical Stocks Recent News

        Date Stock Title
        Apr 16 CMPX Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors
        Related Industries: Biotechnology
        Related Stock Lists: Angiogenesis Antibodies Clinical Medicine Compugen Human Diseases Immune Checkpoint Immune System Immunogen Life Sciences Medicine Monoclonal Antibody Therapy Oncology Tumor Tumor Microenvironment
        Oncology Focused Biopharmaceutical

        Oncology focused biopharmaceuticals are drugs and treatments that are specifically designed to target cancer cells. These treatments are typically developed through research and clinical trials to target specific types of cancer, such as breast cancer, lung cancer, or leukemia. They may include targeted therapies, immunotherapies, and gene therapies.

        Browse All Tags